Viewing Study NCT05623267


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2026-06-13 @ 11:57 PM
Study NCT ID: NCT05623267
Status: RECRUITING
Last Update Posted: 2023-08-07
First Post: 2022-11-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT
Sponsor: Sun Yat-sen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Limited Stage Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Limited-stage Small-cell Lung Cancer(LS-SCLC) View
None Minimal Residual Disease(MRD) View
None Immunotherapy View